Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Bristol Myers Squibb (BMYMP) Return on Capital Employed (2016 - 2025)

Historic Return on Capital Employed for Bristol Myers Squibb (BMYMP) over the last 16 years, with Q4 2025 value amounting to 0.07%.

  • Bristol Myers Squibb's Return on Capital Employed rose 2600.0% to 0.07% in Q4 2025 from the same period last year, while for Dec 2025 it was 0.07%, marking a year-over-year increase of 2600.0%. This contributed to the annual value of 0.07% for FY2025, which is 2500.0% up from last year.
  • Latest data reveals that Bristol Myers Squibb reported Return on Capital Employed of 0.07% as of Q4 2025, which was up 2600.0% from 0.1% recorded in Q3 2025.
  • In the past 5 years, Bristol Myers Squibb's Return on Capital Employed registered a high of 0.02% during Q1 2023, and its lowest value of 0.32% during Q4 2024.
  • For the 5-year period, Bristol Myers Squibb's Return on Capital Employed averaged around 0.11%, with its median value being 0.08% (2025).
  • Per our database at Business Quant, Bristol Myers Squibb's Return on Capital Employed crashed by -2900bps in 2024 and then soared by 2600bps in 2025.
  • Over the past 5 years, Bristol Myers Squibb's Return on Capital Employed (Quarter) stood at 0.02% in 2021, then tumbled by -54bps to 0.03% in 2022, then grew by 1bps to 0.03% in 2023, then tumbled by -915bps to 0.32% in 2024, then soared by 80bps to 0.07% in 2025.
  • Its Return on Capital Employed was 0.07% in Q4 2025, compared to 0.1% in Q3 2025 and 0.11% in Q2 2025.